Neurogene Inc.
NGNE
Positions held
Your positionsNGNE isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $530.30M | Enterprise value | $313.25M | Trailing P/E | — | Forward P/E | -4.66 |
| PEG | — | Price / book | 1.93 | Beta | 2.09 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -45.3% | ROA | -28.0% | Debt / equity | 0.04 |
| Current ratio | 10.65 | Free cash flow | -$48.08M | Analyst recommendation | none | Mean target | $77.88 |
| 52w high | $43.66 | 52w low | $15.93 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$34.5M | -$30.9M | -$24.7M | -$21.0M | -$22.0M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$36.7M | -$33.3M | -$27.5M | -$23.8M | -$26.1M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.9M | $0.0M | $0.0M |
| Op margin | — | -8930.3% | — | — |
| Net income | -$90.4M | -$75.1M | -$36.3M | -$55.2M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$103M | -$82.6M | -$55.6M | -$56.5M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · JPMorgan Initiates Neurogene at Overweight With $60 Price Target
2026-10-05 · Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-09-08 · Neurogene to Participate in H.C. Wainwright 28th Annual Global Investment Conference
2026-09-04 · Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-08-11 · Neurogene: Q2 Earnings Snapshot
2026-08-11 · Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates
2026-08-04 · Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Price (daily)
Full chart · RSI · MACD · patterns